Sage Therapeutics, Inc.

Historical 13F Holders

Symbol
SAGE
CUSIP
78667J108
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 78667J108 since 12/18/2024, largest first.

Filer % of Class Filed
BlackRock, Inc. 13G/A 7.2% 4/17/2025
Event 3/31/2025
Vanguard Group Inc 13G/A 5.2% 7/29/2025
Event 6/30/2025
Under 5%, checked the "5 percent or less" box, or amended by a later filing (6)
RTW Investments, LP 13G/A
4.9% 2/14/2025
Event 12/31/2024
BB Biotech AG 13G/A
1.9% 1/17/2025
Event 1/13/2025
Morgan Stanley 13G/A
1.6% 3/6/2025
Event 2/28/2025
FMR LLC 13G/A
0.8% 3/7/2025
Event 2/28/2025
Biogen Inc. 13D/A
0% 7/30/2025
Event 7/30/2025
Madison Avenue Partners, LP 13G/A
0% 11/14/2025
Event 9/30/2025

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q2 1 1.00 $9
2026 Q1 1 1.00 $9
2025 Q4 2 22.2 k $460k
2025 Q3 5 56.4 k $494k
2025 Q2 196 48.9 M $446M
2025 Q1 201 51.8 M $411M
2024 Q4 180 51.2 M $278M
2024 Q3 178 51.4 M $374M
2024 Q2 197 53.5 M $581M
2024 Q1 207 58.5 M $1.10B
2023 Q4 204 56.1 M $1.22B
2023 Q3 198 58.8 M $1.21B
2023 Q2 229 54.1 M $2.54B
2023 Q1 219 53.0 M $2.22B
2022 Q4 213 51.6 M $2.44B
2022 Q3 206 51.5 M $2.02B
2022 Q2 217 51.1 M $1.65B
2022 Q1 217 49.9 M $1.65B
2021 Q4 222 50.2 M $2.14B
2021 Q3 232 49.1 M $2.17B
2021 Q2 265 50.7 M $2.88B
2021 Q1 268 53.1 M $3.97B
2020 Q4 252 53.8 M $4.65B
2020 Q3 236 53.7 M $3.28B
2020 Q2 224 54.0 M $2.25B
2020 Q1 236 55.2 M $1.59B
2019 Q4 276 56.0 M $4.04B
2019 Q3 290 58.3 M $8.18B
2019 Q2 279 58.1 M $10.6B
2019 Q1 277 56.3 M $8.95B
2018 Q4 256 49.8 M $4.76B
2018 Q3 280 49.2 M $6.95B
2018 Q2 273 48.8 M $7.64B
2018 Q1 254 47.6 M $7.65B
2017 Q4 230 44.1 M $7.26B
2017 Q3 185 39.4 M $2.46B
2017 Q2 197 38.4 M $3.06B
2017 Q1 200 37.9 M $2.69B
2016 Q4 168 36.7 M $1.88B
2016 Q3 156 37.8 M $1.74B
2016 Q2 152 30.2 M $918M
2016 Q1 144 29.1 M $932M
2015 Q4 139 23.5 M $1.37B
2015 Q3 135 27.3 M $1.17B
2015 Q2 125 26.4 M $1.93B
2015 Q1 93 21.5 M $1.08B
2014 Q4 74 20.3 M $736M
2014 Q3 52 18.9 M $596M